For instance, treatment of primary ALL samples with the specific TLR2/1 ligand, PAM3CSK4, triggers caspase-8-mediated apoptosis and sensitizes ALL cells to vincristine-mediated toxicity in vitro (Rolf et al., 2015). This evidence concerns the gene CASP8 and acute lymphoblastic leukemia.